<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PSA Rising Prostate Cancer Blog &#187; clinical trials conduct of</title>
	<atom:link href="http://www.psa-rising.com/blog/category/ca/clinical-trials-conduct-of/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.psa-rising.com/blog</link>
	<description></description>
	<lastBuildDate>Tue, 16 Aug 2011 09:39:00 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>U.S. cancer trials near state of crisis, report</title>
		<link>http://www.psa-rising.com/blog/2010/04/u-s-cancer-trials-in-crisis/</link>
		<comments>http://www.psa-rising.com/blog/2010/04/u-s-cancer-trials-in-crisis/#comments</comments>
		<pubDate>Fri, 16 Apr 2010 21:04:47 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cancer research]]></category>
		<category><![CDATA[clinical trials conduct of]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=2289</guid>
		<description><![CDATA[The U.S. government’s cancer research network is in severe disarray according to a report by the Institute of Medicine. Waste and inefficiency cause 40% of all late-stage government funded cancer trials to be abandoned before completion, the report found. Shannon Pettypiece at Bloomberg.com and Liz Jones at FierceBiotech say the report paints a doomladen picture. [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2010/04/u-s-cancer-trials-in-crisis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Avastin costs too much, poorly run clinical trials may kill</title>
		<link>http://www.psa-rising.com/blog/2006/02/avastin-costs-too-much-and-trials-may-kill/</link>
		<comments>http://www.psa-rising.com/blog/2006/02/avastin-costs-too-much-and-trials-may-kill/#comments</comments>
		<pubDate>Wed, 15 Feb 2006 07:17:05 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Avastin]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cancer Treatments]]></category>
		<category><![CDATA[cardiovascular]]></category>
		<category><![CDATA[Clinical trials]]></category>
		<category><![CDATA[clinical trials conduct of]]></category>
		<category><![CDATA[Colorectal]]></category>
		<category><![CDATA[bowel perforation]]></category>
		<category><![CDATA[drug costs]]></category>
		<category><![CDATA[drug safety]]></category>
		<category><![CDATA[Genentech]]></category>

		<guid isPermaLink="false">http://psa-rising.com/blog/index.php/2006/02/15/avastin-costs-too-much-and-kills-you-too/</guid>
		<description><![CDATA[February 15, 2006. Today&#8217;s New York Times runs a business section story by Alex Berenson about Genentech&#8217;s Avastin, A Cancer Drug Shows Promise, at a Price That Many Can&#8217;t Pay. Buried on the second page Berenson mentions this week&#8217;s news about deaths in a clinical trial of Avastin plus chemotherapy. The patients were taking Avastin [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2006/02/avastin-costs-too-much-and-trials-may-kill/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

